Brooks Laboratories Ltd.
Snapshot View

105.85 +4.70 ▲4.7%

31 January 2023, 04:01:00 PM
Volume: 6,681

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.brookslabs.net
Market Cap 258.89 Cr.
Enterprise Value(EV) 280.35 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -8.82 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 32.54 Trailing Twelve Months Ending 2022-09
Book Value / Share 32.47 Trailing Twelve Months Ending 2022-09
Price to Book Value 3.26 Calculated using Price: 105.85
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 2.47 Cr. 24,702,812 Shares
FaceValue 10
Company Profile
The Company was originally incorporated as Brooks Laboratories Limited on January 23, 2002. Company was initially promoted for manufacturing of latest molecules in Injectables, tablets and dry syrups for the domestic customers. The Company set up a facility for manufacturing Tablets, Dry Syrup and Injectables, which was supported by a research and development centre at Baddi, Himachal Pradesh. The Company started its commercial production in the month of June 2006 and became profitable from the very first year of its production.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+4.65%
1 Week
+2.57%
1 Month
-3.20%
3 Month
+0.81%
6 Month
+26.01%
1 Year
+8.73%
2 Year
+69.77%
5 Year
+23.15%
10 Year
+589.58%
2 years 2021-03 2022-03
Return on Equity (%) -24.48 -27.16
Return on Capital Employed (%) -5.33 -21.03
Return on Assets (%) -11.95 -10.83

Balance Sheet View Details >>

Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 79 63 80
Non Curr. Liab. 19 11 4
Curr. Liab. 64 49 60
Minority Int. 71 59
Equity & Liab. 162 195 203
Non Curr. Assets 112 133 149
Curr. Assets 47 61 54
Misc. Exp. not W/O
Total Assets 162 195 203

Profit Loss View Details >>

Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 77 91 83
Other Income 1 1 1
Total Income 78 92 83
Total Expenditure -77 -105 -111
PBIDT 1 -13 -27
Interest -3 -3 -3
Depreciation -7 -7 -8
Taxation -10 5 7
Exceptional Items
PAT -19 -19 -31
Minority Interest 3 9
Share Associate 0
Other Related Items
Consolidated Net Profit -19 -16 -22
Adjusted EPS -8 -7 -9

Cash Flow View Details >>

Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 4 -37
Cash Fr. Inv. -5 -25
Cash Fr. Finan. 1 64
Net Change 0 2
Cash & Cash Eqvt 1 3

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 66.41 66.41 66.41 66.41 66.41 66.41 66.41 66.41 66.41
Public 33.59 33.59 33.59 33.59 33.59 33.59 33.59 33.59 33.59
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 31 Jan 2023
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal Ballot
Fri, 27 Jan 2023
Board Meeting Outcome for Revised Outcome Of Board Meeting Dated 25Th January 2023
Revised outcome of Board meeting dated 25th January 2023
Wed, 25 Jan 2023
Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Rights Issue And Postal Ballot Notice
outcome of Board Meeting for approval of Rights Issue and Postal Ballot Notice

Technical Scans View Details >>

Tue, 31 Jan 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 248,331.17 1,034.50 -1.6%
Divi's Laboratories Ltd. 88,067.87 3,315.30 -1.5%
Cipla Ltd. 82,086.54 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. 72,004.82 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. 61,188.28 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. 51,492.78 1,521.45 -1.7%
Abbott India Ltd. 44,288.65 20,785.15 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.96 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-09 29.43 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-12 31.11 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.72 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.88 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.96 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-09 50.23 20,785.15 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.68 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-09 7.26 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-12 3.62 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.26 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.22 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.08 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-09 16.32 20,785.15 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 0.00 20,785.15 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 29.95 20,785.15 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 29.95 20,785.15 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,785.15 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 798.70 20,785.15 -0.9%

FAQ's On Brooks Laboratories Ltd.

What is Brooks Laboratories share price?

Can I buy Brooks Laboratories shares now?

What is the Market Cap of Brooks Laboratories?

What are the key metrics to analyse Brooks Laboratories?

What is the 52 Week High and Low of Brooks Laboratories?

What is the trend of Brooks Laboratories share price?